MiniMed Group (MMED) CEO Dallara Que files initial insider Form 3

Rhea-AI Filing Summary

MiniMed Group, Inc. director and Chief Executive Officer Dallara Que filed an initial ownership report on Form 3. This filing establishes Que’s status as an insider of the company but does not list any transactions or specific share holdings.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Dallara Que

(Last) (First) (Middle)

C/O 18000 DEVONSHIRE STREET

(Street)

NORTHRIDGE CA 91325

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/06/2026

3. Issuer Name and Ticker or Trading Symbol
MiniMed Group, Inc. [ MMED ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Bryan F. Kelly, attorney-in-fact	03/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does Dallara Que’s Form 3 filing mean for MiniMed Group (MMED)?

The Form 3 shows that Dallara Que is an insider of MiniMed Group as both director and Chief Executive Officer. It is an initial ownership statement and does not disclose any purchases, sales, or other transactions in the company’s securities.

Does the MiniMed Group (MMED) Form 3 show any stock transactions by Dallara Que?

No, this Form 3 does not list any transactions by Dallara Que. The transaction summary shows zero buys, zero sells, zero exercises, and no gifts or tax withholdings, indicating only an initial insider ownership report without trading activity.

What insider role does Dallara Que hold at MiniMed Group (MMED)?

Dallara Que is identified as both a director and an officer of MiniMed Group, serving as Chief Executive Officer. The filing also shows Que is not categorized as a ten percent owner, clarifying the nature of their insider status at the company.

Does the MiniMed Group (MMED) Form 3 include any derivative securities for Dallara Que?

No, the derivative summary in the Form 3 is empty, indicating no listed options, warrants, or other derivative positions for Dallara Que in this filing. It functions purely as an initial insider designation without derivative holdings detail.

Are there any notable footnotes in Dallara Que’s Form 3 for MiniMed Group (MMED)?

The Form 3 includes a footnotes section, but it does not contain substantive explanatory text in this data. There are no stated limitations on voting or investment power or references to trusts, LLCs, or trading plans in the provided information.